Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) Sees Large Growth in Short Interest

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totaling 79,267 shares, an increase of 284.8% from the April 30th total of 20,598 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 61,665 shares, the days-to-cover ratio is currently 1.3 days.

Otsuka Trading Up 3.8%

OTSKY stock traded up $1.33 during mid-day trading on Friday, hitting $36.46. 7,612 shares of the company were exchanged, compared to its average volume of 37,048. The company has a quick ratio of 1.67, a current ratio of 2.17 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $39.16 billion and a P/E ratio of 15.38. The business has a fifty day simple moving average of $34.87 and a 200-day simple moving average of $31.79. Otsuka has a 12-month low of $21.68 and a 12-month high of $37.52.

Otsuka (OTCMKTS:OTSKY) last announced its earnings results on Tuesday, April 28th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.16. Otsuka had a return on equity of 12.33% and a net margin of 15.01%.The company had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $3.78 billion. Otsuka has set its FY 2026 guidance at 1.610-1.610 EPS. On average, equities research analysts predict that Otsuka will post 1.99 earnings per share for the current fiscal year.

Analyst Ratings Changes

OTSKY has been the topic of several research analyst reports. Zacks Research raised Otsuka from a “strong sell” rating to a “hold” rating in a report on Tuesday, March 31st. The Goldman Sachs Group lowered Otsuka from a “strong-buy” rating to a “strong sell” rating in a research report on Friday, February 27th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold”.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.